United Therapeutics Corporation
NDC labeler code: 66302
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- TreprostinilTyvaso Dpi, Orenitram, Remodulin · 21 products
- TadalafilCialis, Alyq, Adcirca · 1 product
- WaterSterile Water, Bacteriostatic Water, Insulin Diluting Medium for Kirsty · 1 product
- DinutuximabUnituxin · 1 product
FDA applications for these products
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| May 23, 2022 | NDA214324 | Treprostinil TYVASO DPI | United Therap |
| March 10, 2015 | BLA125516 | Dinutuximab UNITUXIN | United Therap |
| December 20, 2013 | NDA203496 | Treprostinil ORENITRAM | United Therap |
| July 30, 2009 | NDA022387 | Treprostinil TYVASO | United Therap |
| May 22, 2009 | NDA022332 | Tadalafil ADCIRCA | Eli Lilly Co |
| May 21, 2002 | NDA021272 | Treprostinil, Water REMODULIN | United Therap |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2018
-
August 14, 2018 · Class III · Terminated · D-1188-2018 · Treprostinil
Defective Delivery System: Water ingress through the lower water cup sensor of the device.
Tyvaso Inhalation System Patient a) Starter Kit with TYVASO (treprostinil) Inhalation Solution. Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) (NDC 66302-206-01) b) TD-300/A Replacement Device Kit Material Number RTP3099 RX Onl
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026